MYIA
CLBT icon

Mount Yale Investment Advisors’s Cellebrite CLBT Stock Holding History

Mount Yale Investment Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,801
Closed -$157K – 834
2025
Q2 		$157K Buy
+9,801
New +$175K 0.01% 582

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Mount Yale Investment Advisors's CLBT Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 9,801 shares — an estimated $157K sold.

Mount Yale Investment Advisors first reported a position in CLBT in Q2 2025 and held it in 1 quarter. The position peaked at $157K in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 9,801 Cellebrite shares in Q3 2025, an estimated $157K.
  • Mount Yale Investment Advisors first reported a position in Cellebrite in Q2 2025 and held it in 1 quarter.
  • Mount Yale Investment Advisors's Cellebrite position peaked at $157K in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.